Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Analgesics, Opioid | 15 | 2024 | 1468 | 3.280 |
Why?
|
Opioid-Related Disorders | 8 | 2024 | 419 | 3.130 |
Why?
|
Drug Overdose | 4 | 2024 | 97 | 2.430 |
Why?
|
Naloxone | 4 | 2024 | 106 | 1.800 |
Why?
|
Buprenorphine | 4 | 2024 | 106 | 1.770 |
Why?
|
Prescription Drug Monitoring Programs | 4 | 2022 | 13 | 1.760 |
Why?
|
Benzodiazepines | 3 | 2024 | 167 | 1.690 |
Why?
|
Narcotic Antagonists | 6 | 2024 | 155 | 1.590 |
Why?
|
Opiate Substitution Treatment | 3 | 2024 | 35 | 1.340 |
Why?
|
Chronic Pain | 2 | 2024 | 262 | 1.330 |
Why?
|
Pharmacists | 5 | 2023 | 97 | 1.090 |
Why?
|
Practice Patterns, Physicians' | 8 | 2024 | 1302 | 0.970 |
Why?
|
Cross-Sectional Studies | 12 | 2024 | 4492 | 0.930 |
Why?
|
Focus Groups | 2 | 2024 | 285 | 0.930 |
Why?
|
Drug Prescriptions | 7 | 2024 | 311 | 0.920 |
Why?
|
Methadone | 1 | 2024 | 214 | 0.840 |
Why?
|
Pharmacies | 1 | 2022 | 16 | 0.840 |
Why?
|
Motivation | 2 | 2023 | 516 | 0.820 |
Why?
|
Prescription Drugs | 2 | 2020 | 61 | 0.820 |
Why?
|
Hypnotics and Sedatives | 1 | 2024 | 213 | 0.820 |
Why?
|
Prescriptions | 4 | 2023 | 60 | 0.790 |
Why?
|
Fear | 1 | 2023 | 253 | 0.780 |
Why?
|
Self Efficacy | 1 | 2023 | 299 | 0.760 |
Why?
|
Health Policy | 2 | 2020 | 278 | 0.750 |
Why?
|
Social Desirability | 1 | 2020 | 20 | 0.730 |
Why?
|
Health Services Accessibility | 2 | 2024 | 831 | 0.730 |
Why?
|
Preceptorship | 1 | 2020 | 44 | 0.700 |
Why?
|
Alcoholism | 1 | 2023 | 332 | 0.690 |
Why?
|
Education, Pharmacy | 1 | 2020 | 57 | 0.670 |
Why?
|
Health Risk Behaviors | 1 | 2017 | 6 | 0.570 |
Why?
|
Child Restraint Systems | 1 | 2017 | 5 | 0.570 |
Why?
|
Vaccines | 1 | 2022 | 399 | 0.570 |
Why?
|
Community Pharmacy Services | 1 | 2017 | 14 | 0.570 |
Why?
|
Health Expenditures | 3 | 2024 | 202 | 0.550 |
Why?
|
Sickness Impact Profile | 1 | 2017 | 138 | 0.540 |
Why?
|
Physicians | 1 | 2023 | 854 | 0.500 |
Why?
|
Budgets | 1 | 2015 | 24 | 0.490 |
Why?
|
Perception | 1 | 2017 | 349 | 0.480 |
Why?
|
Texas | 7 | 2024 | 6449 | 0.480 |
Why?
|
United States | 11 | 2024 | 15861 | 0.470 |
Why?
|
Attitude of Health Personnel | 2 | 2018 | 901 | 0.450 |
Why?
|
Mothers | 1 | 2017 | 416 | 0.440 |
Why?
|
Coronavirus Infections | 1 | 2020 | 625 | 0.430 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 700 | 0.420 |
Why?
|
Intention | 2 | 2022 | 114 | 0.390 |
Why?
|
Qualitative Research | 3 | 2024 | 642 | 0.390 |
Why?
|
Interrupted Time Series Analysis | 2 | 2020 | 32 | 0.360 |
Why?
|
Hypoglycemic Agents | 1 | 2015 | 599 | 0.360 |
Why?
|
Humans | 32 | 2024 | 270740 | 0.350 |
Why?
|
Adult | 16 | 2024 | 82040 | 0.330 |
Why?
|
Insulin | 1 | 2015 | 1483 | 0.320 |
Why?
|
Health Care Surveys | 2 | 2023 | 418 | 0.320 |
Why?
|
West Virginia | 2 | 2017 | 7 | 0.290 |
Why?
|
Logistic Models | 2 | 2024 | 3444 | 0.280 |
Why?
|
Multiple Sclerosis | 2 | 2020 | 375 | 0.270 |
Why?
|
Young Adult | 7 | 2024 | 22251 | 0.240 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 1412 | 0.240 |
Why?
|
Patient Discharge | 3 | 2024 | 698 | 0.230 |
Why?
|
Nonprescription Drugs | 1 | 2024 | 50 | 0.220 |
Why?
|
Help-Seeking Behavior | 1 | 2023 | 2 | 0.220 |
Why?
|
Pain, Postoperative | 3 | 2024 | 662 | 0.220 |
Why?
|
Female | 16 | 2024 | 148940 | 0.220 |
Why?
|
Parents | 2 | 2022 | 1082 | 0.210 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2022 | 1235 | 0.210 |
Why?
|
Melanoma | 3 | 2024 | 5595 | 0.210 |
Why?
|
Middle Aged | 11 | 2024 | 90352 | 0.210 |
Why?
|
Faculty, Pharmacy | 1 | 2020 | 6 | 0.180 |
Why?
|
Reproducibility of Results | 2 | 2023 | 6177 | 0.180 |
Why?
|
Male | 11 | 2024 | 128315 | 0.180 |
Why?
|
Electronic Health Records | 2 | 2024 | 850 | 0.170 |
Why?
|
Drug Utilization | 1 | 2020 | 188 | 0.170 |
Why?
|
Students, Pharmacy | 1 | 2020 | 64 | 0.170 |
Why?
|
Self Report | 1 | 2023 | 796 | 0.160 |
Why?
|
Controlled Substances | 1 | 2018 | 14 | 0.160 |
Why?
|
Internet | 1 | 2023 | 690 | 0.160 |
Why?
|
Cohort Studies | 4 | 2024 | 9470 | 0.150 |
Why?
|
Surveys and Questionnaires | 2 | 2024 | 5923 | 0.150 |
Why?
|
Hydrocodone | 1 | 2018 | 52 | 0.150 |
Why?
|
Geriatrics | 1 | 2018 | 90 | 0.150 |
Why?
|
Comorbidity | 1 | 2024 | 2394 | 0.150 |
Why?
|
Education, Pharmacy, Continuing | 1 | 2017 | 1 | 0.140 |
Why?
|
Automobiles | 1 | 2017 | 10 | 0.140 |
Why?
|
Pain Management | 2 | 2024 | 712 | 0.140 |
Why?
|
Cost of Illness | 1 | 2020 | 505 | 0.140 |
Why?
|
Vaccination | 1 | 2022 | 1166 | 0.130 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 964 | 0.130 |
Why?
|
Income | 1 | 2017 | 235 | 0.130 |
Why?
|
Educational Status | 1 | 2017 | 392 | 0.130 |
Why?
|
Cancer Pain | 1 | 2020 | 345 | 0.130 |
Why?
|
Pandemics | 2 | 2023 | 1610 | 0.120 |
Why?
|
Rural Population | 1 | 2017 | 292 | 0.120 |
Why?
|
Cluster Analysis | 1 | 2017 | 1075 | 0.120 |
Why?
|
Retrospective Studies | 6 | 2024 | 39890 | 0.100 |
Why?
|
Adolescent | 5 | 2024 | 32767 | 0.100 |
Why?
|
Skin Neoplasms | 2 | 2024 | 4895 | 0.090 |
Why?
|
Risk Assessment | 1 | 2023 | 6764 | 0.090 |
Why?
|
Aged | 6 | 2024 | 73333 | 0.080 |
Why?
|
Breast Neoplasms | 2 | 2020 | 16215 | 0.070 |
Why?
|
Child, Preschool | 1 | 2022 | 17061 | 0.060 |
Why?
|
Child | 2 | 2024 | 30559 | 0.060 |
Why?
|
Treatment Outcome | 2 | 2023 | 33737 | 0.060 |
Why?
|
Inappropriate Prescribing | 1 | 2024 | 54 | 0.060 |
Why?
|
Insurance, Health | 1 | 2024 | 261 | 0.050 |
Why?
|
Antidepressive Agents | 1 | 2024 | 335 | 0.050 |
Why?
|
Anticonvulsants | 1 | 2024 | 430 | 0.050 |
Why?
|
Thyroid Gland | 1 | 2023 | 366 | 0.040 |
Why?
|
Students | 1 | 2023 | 333 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 540 | 0.040 |
Why?
|
Immunotherapy | 2 | 2024 | 3557 | 0.040 |
Why?
|
Models, Economic | 1 | 2020 | 102 | 0.040 |
Why?
|
Health Care Costs | 1 | 2024 | 699 | 0.040 |
Why?
|
Drug Monitoring | 1 | 2020 | 352 | 0.040 |
Why?
|
Drug Substitution | 1 | 2018 | 87 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2024 | 657 | 0.040 |
Why?
|
Neoplasms | 1 | 2024 | 15927 | 0.040 |
Why?
|
Quality Improvement | 1 | 2024 | 914 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 1137 | 0.040 |
Why?
|
Linear Models | 1 | 2020 | 1093 | 0.040 |
Why?
|
Anxiety | 1 | 2023 | 1240 | 0.030 |
Why?
|
Clinical Decision-Making | 1 | 2018 | 533 | 0.030 |
Why?
|
Chronic Disease | 1 | 2020 | 1824 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2020 | 2057 | 0.030 |
Why?
|
Mastectomy | 1 | 2020 | 1553 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 3530 | 0.030 |
Why?
|
Hospitalization | 1 | 2020 | 2167 | 0.020 |
Why?
|
Survival Rate | 1 | 2024 | 12541 | 0.020 |
Why?
|
Time Factors | 1 | 2020 | 13006 | 0.020 |
Why?
|
Risk Factors | 1 | 2020 | 17888 | 0.010 |
Why?
|